StreetInsider.com News Articles

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial Results

Thu, 22 Oct 2026 16:10:00 -0400

ATLANTA, Oct. 22, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2026 financial results will be released on Thursday, November 5, 2026, after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question-and-answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial Results

Thu, 22 Oct 2026 16:10:00 -0400

Artivion rises as Jefferies initiates at buy, sees ’attractive entry point’

Tue, 20 Oct 2026 11:03:45 -0400

Investing.com -- Artivion Inc (NYSE:AORT) shares gained 4.2% Tuesday after Jefferies initiated coverage on the cardiovascular medical device maker with a Buy rating and a $31 price target, framing the company as a compelling play on aortic surgery growth. The bullish call reflects optimism surrounding Artivion’s expanding product pipeline, which Wall Street expects to drive double-digit revenue expansion alongside expanding profit margins.

Jefferies analyst Michael Sarcone highlighted the upcoming U.S. adoption trajectory for key products, including the AMDS hybrid prosthesis and the Nexus endovascular stent graft. Conversations with healthcare providers indicate that product differentiation and unmet

Jefferies Starts Artivion Inc. (AORT) at Buy

Tue, 20 Oct 2026 03:39:47 -0400

Jefferies analyst Michael Sarcone initiates coverage on Artivion Inc. (NYSE: AORT) with a Buy rating and a price target of $31.00.

The analyst comments: “We init coverage w/ Buy rating, $31 PT. AORT is an aortic surgical play w/ a healthy cadence of new product launches we expect to support DD sales growth + margin and multiple expansion. Our doc convos suggest product differentiation/market need should support healthy US uptake of AMDS + Nexus, which are GM accretive + contribute to EBITDA margin expansion. We view shares at a below-peer 12x EBITDA as an attractive entry point.

AORT is focused on aortic

Jefferies Starts Artivion Inc. (AORT) at Buy

Tue, 20 Oct 2026 03:39:47 -0400

Jefferies analyst Michael Sarcone initiates coverage on Artivion Inc. (NYSE: AORT) with a Buy rating and a price target of $31.00.

AORT is focused on aortic

Form 4 ARTIVION, INC. For: Sep 10 Filed by: GREEN ANDREW M

Fri, 11 Sep 2026 17:29:00 -0400

si-local-file:///var/storage/secattach/20260911/27053753.html

Form 144 ARTIVION, INC. Filed by: GREEN ANDREW M

Thu, 10 Sep 2026 11:43:00 -0400

si-local-file:///var/storage/secattach/20260910/27047134.html

Form 4 ARTIVION, INC. For: Sep 02 Filed by: GREEN ANDREW M

Fri, 04 Sep 2026 14:15:00 -0400

si-local-file:///var/storage/secattach/20260904/27029384.html

Form 144 ARTIVION, INC. Filed by: GREEN ANDREW M

Thu, 03 Sep 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260903/27026040.html

Form 144 ARTIVION, INC. Filed by: GREEN ANDREW M

Wed, 02 Sep 2026 16:42:00 -0400

si-local-file:///var/storage/secattach/20260902/27019788.html

Form 144 ARTIVION, INC. Filed by: Stanton Marshall S.

Thu, 27 Aug 2026 14:36:00 -0400

si-local-file:///var/storage/secattach/20260827/26988957.html

Form 144 ARTIVION, INC. Filed by: Stanton Marshall S.

Thu, 27 Aug 2026 14:36:00 -0400

si-local-file:///var/storage/secattach/20260827/26988957.html

Form 4 ARTIVION, INC. For: Aug 19 Filed by: Mackin James P

Thu, 20 Aug 2026 14:11:00 -0400

si-local-file:///var/storage/secattach/20260820/26955555.html

Form 4 ARTIVION, INC. For: Aug 19 Filed by: Mackin James P

Thu, 20 Aug 2026 14:11:00 -0400

si-local-file:///var/storage/secattach/20260820/26955555.html

Form 144 ARTIVION, INC. Filed by: Mackin James P

Wed, 19 Aug 2026 15:46:00 -0400

si-local-file:///var/storage/secattach/20260819/26949836.html

Form 144 ARTIVION, INC. Filed by: Mackin James P

Wed, 19 Aug 2026 15:46:00 -0400

si-local-file:///var/storage/secattach/20260819/26949836.html

Artivion Inc. (AORT) PT Raised to $40 at Canaccord

Tue, 18 Aug 2026 05:18:17 -0400

Canaccord analyst William Plovanic raised the price target on Artivion Inc. (NYSE: AORT) to $40.00 (from $39.00) while maintaining a Buy rating.

The analyst comments "This note serves as a model update for our Artivion estimates. We are adjusting our revenue estimates to reflect the additional data contained in the company’s 10-Q filing for Q2. Our price target is raised to $40 from $39 due to a change in the comp group multiple, as our 2027 revenue estimate is unchanged. Maintain BUY."

Artivion Inc. (AORT) PT Raised to $40 at Canaccord

Tue, 18 Aug 2026 05:18:17 -0400

Canaccord analyst William Plovanic raised the price target on Artivion Inc. (NYSE: AORT) to $40.00 (from $39.00) while maintaining a Buy rating.

Form 4 ARTIVION, INC. For: Aug 14 Filed by: GREEN ANDREW M

Mon, 17 Aug 2026 15:19:00 -0400

si-local-file:///var/storage/secattach/20260817/26937673.html

Form 4 ARTIVION, INC. For: Aug 14 Filed by: GREEN ANDREW M

Mon, 17 Aug 2026 15:19:00 -0400

si-local-file:///var/storage/secattach/20260817/26937673.html

Form 4 ARTIVION, INC. For: Aug 14 Filed by: Berry Lance A

Mon, 17 Aug 2026 15:18:00 -0400

si-local-file:///var/storage/secattach/20260817/26937668.html

Form 4 ARTIVION, INC. For: Aug 14 Filed by: Berry Lance A

Mon, 17 Aug 2026 15:18:00 -0400

si-local-file:///var/storage/secattach/20260817/26937668.html

Form 144 ARTIVION, INC. Filed by: Berry Lance A

Fri, 14 Aug 2026 15:59:00 -0400

si-local-file:///var/storage/secattach/20260814/26929770.html

Form 144 ARTIVION, INC. Filed by: Berry Lance A

Fri, 14 Aug 2026 15:59:00 -0400

si-local-file:///var/storage/secattach/20260814/26929770.html

Form 144 ARTIVION, INC. Filed by: GREEN ANDREW M

Fri, 14 Aug 2026 15:18:00 -0400

si-local-file:///var/storage/secattach/20260814/26929434.html